Molecular Classification and Emerging Targeted Therapy in Endometrial Cancer

Research output: Contribution to journalReview article

Abstract

Recent advances in molecular studies, especially genome-wide analyses, have revealed the landscape of genomic alterations present in endometrial carcinomas, and have provided valuable insight into the pathogenesis of this disease. The current challenges are in developing a molecular-morphologic classification system to enhance traditional pathologic diagnosis and in determining the optimal approach to using this new information to guide clinical management. Molecular assays may be particularly beneficial in allowing the earlier detection of endometrial cancer or precursor lesions and in guiding personalized treatment approaches. In this review, we describe the current molecular landscape of endometrial cancers, efforts underway to incorporate molecular alterations into the current classification systems, and the development of diagnostic tools for the early detection of endometrial cancer. Finally, we present opportunities for using these data to tailor therapeutic strategies. A comprehensive understanding of the molecular alterations responsible for the origination, relapse, and resistance patterns of this disease will ultimately improve outcomes for patients with endometrial cancer.

Original languageEnglish (US)
Pages (from-to)26-35
Number of pages10
JournalInternational Journal of Gynecological Pathology
Volume39
Issue number1
DOIs
StatePublished - Jan 1 2020

    Fingerprint

Keywords

  • Endometrial cancer
  • Molecular classification
  • Targeted therapy

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Obstetrics and Gynecology

Cite this